Bristol-Myers Squibb (BMY) FY2022 results: revenue $46.2 billion, down 0.5% on the year
Bristol-Myers Squibb Co. (BMY) reported revenue of $46.2 billion for fiscal 2022, the year ended 31 December 2022, down 0.5% on the year before. Net income was $6.3 billion, down 9.5%, and diluted earnings per share $2.95. The figures are the company's own, from the 10-K it filed with the SEC on 14 February 2023.
Revenue
$46.2 billion
-0.5% on the year
FY2015FY2022
Operating margin
16.7%
17.5% a year earlier
FY2015FY2022
Net income
$6.3 billion
-9.5% on the year
FY2015FY2022
Diluted EPS
$2.95
-5.4% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
13,066
16,207
14,052
-19.4%
Capital expenditure
1,118
973
753
+14.9%
Free cash flow
11,948
15,234
13,299
-21.6%
Free cash flow margin
25.9%
32.8%
31.3%
Cash from investing
-1,062
-538
-10,859
Cash from financing
-16,962
-16,224
-1,151
Depreciation and amortisation
10,276
10,686
10,380
-3.8%
Share-based compensation
457
583
779
-21.6%
Buybacks
8,001
6,287
1,546
+27.3%
Dividends paid
4,634
4,396
4,075
+5.4%
Dividend per share
$2.19
$2.01
$1.84
+9.0%
Diluted shares, weighted
2,146m
2,245m
2,258m
-4.4%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
31,061
35,946
37,822
-13.6%
Non-controlling interest
57.0
60.0
60.0
-5.0%
Short-term borrowings
n/a
4,948
n/a
Debt
39,320
44,369
50,676
-11.4%
Operating lease liabilities
1,261
874
833
+44.3%
Other liabilities
25,121
23,117
29,090
+8.7%
Total liabilities and equity
96,820
109,314
118,481
-11.4%
Fixed assets
6,255
6,049
5,886
+3.4%
Goodwill
21,149
20,502
20,547
+3.2%
Intangible assets
35,859
42,527
53,243
-15.7%
Investments
130
2,987
1,718
-95.6%
Cash and equivalents
9,123
13,979
14,546
-34.7%
Receivables
8,151
7,979
7,219
+2.2%
Inventory
2,339
2,095
2,074
+11.6%
Other assets
13,814
13,196
13,248
+4.7%
Total assets
96,820
109,314
118,481
-11.4%
10-K for the year ended 31 December 2022, filed 14 February 2023: the filing.